Enrico Maffini

836 total citations
35 papers, 456 citations indexed

About

Enrico Maffini is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Enrico Maffini has authored 35 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Enrico Maffini's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (8 papers) and Multiple Myeloma Research and Treatments (8 papers). Enrico Maffini is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (8 papers) and Multiple Myeloma Research and Treatments (8 papers). Enrico Maffini collaborates with scholars based in Italy, United States and France. Enrico Maffini's co-authors include Benedetto Bruno, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Francesco Lanza, Mario Boccadoro, Alessandro Busca, Marco Allinovi, Angelo Corso Faini and Fabio Malavasi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Enrico Maffini

33 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enrico Maffini Italy 12 204 155 128 104 83 35 456
Moreno Festuccia Italy 15 324 1.6× 156 1.0× 127 1.0× 153 1.5× 107 1.3× 34 529
Amer Beitinjaneh United States 15 286 1.4× 337 2.2× 106 0.8× 146 1.4× 97 1.2× 64 696
Lena Oevermann Germany 12 236 1.2× 198 1.3× 207 1.6× 144 1.4× 33 0.4× 28 534
Motoko Koyama United States 8 291 1.4× 99 0.6× 269 2.1× 115 1.1× 29 0.3× 13 491
Brenda J. Kitchen United States 10 185 0.9× 86 0.6× 196 1.5× 205 2.0× 57 0.7× 11 513
Rik A. Brooimans Netherlands 13 163 0.8× 78 0.5× 142 1.1× 79 0.8× 189 2.3× 22 540
Shuji Ohta Japan 12 92 0.5× 65 0.4× 147 1.1× 115 1.1× 160 1.9× 24 586
Victoria Bordon Belgium 12 118 0.6× 153 1.0× 167 1.3× 184 1.8× 98 1.2× 32 525
Juan Manuel Torres Spain 11 106 0.5× 143 0.9× 323 2.5× 64 0.6× 63 0.8× 23 523
G Prentice Australia 7 210 1.0× 103 0.7× 85 0.7× 71 0.7× 70 0.8× 13 387

Countries citing papers authored by Enrico Maffini

Since Specialization
Citations

This map shows the geographic impact of Enrico Maffini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrico Maffini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrico Maffini more than expected).

Fields of papers citing papers by Enrico Maffini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrico Maffini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrico Maffini. The network helps show where Enrico Maffini may publish in the future.

Co-authorship network of co-authors of Enrico Maffini

This figure shows the co-authorship network connecting the top 25 collaborators of Enrico Maffini. A scholar is included among the top collaborators of Enrico Maffini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrico Maffini. Enrico Maffini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pensato, Umberto, Federica Pondrelli, Chiara De Philippis, et al.. (2024). Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy. Neurological Sciences. 45(8). 4007–4014. 3 indexed citations
2.
3.
Dogliotti, Irene, Mario Levis, Sara Bartoncini, et al.. (2024). Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation. Cancers. 16(5). 865–865. 4 indexed citations
4.
Chirumbolo, Gabriella, Martina Barone, Gianluca Storci, et al.. (2023). A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(5). 302.e1–302.e8. 3 indexed citations
5.
Maffini, Enrico, et al.. (2023). Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management. Frontiers in Pharmacology. 13. 1088031–1088031. 38 indexed citations
6.
Storci, Gianluca, Francesco Barbato, Francesca Ricci, et al.. (2023). Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients. Frontiers in Immunology. 13. 1058739–1058739. 3 indexed citations
7.
8.
Maffini, Enrico, Francesco Barbato, Elisa Dan, et al.. (2022). The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia. Frontiers in Oncology. 12. 1066285–1066285. 3 indexed citations
9.
10.
Cerrano, Marco, Marco Ruella, Miguel‐Angel Perales, et al.. (2020). The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice. Frontiers in Immunology. 11. 888–888. 49 indexed citations
11.
Lanza, Francesco, Enrico Maffini, Francesco Saraceni, et al.. (2020). New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia. Minerva Medica. 111(5). 478–490. 2 indexed citations
12.
Maffini, Enrico, Francesco Saraceni, & Francesco Lanza. (2019). Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia. SHILAP Revista de lepidopterología. 1(2). 85–93. 13 indexed citations
13.
Maffini, Enrico, Barry E. Storer, Brenda M. Sandmaier, et al.. (2018). Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma. Haematologica. 104(2). 380–391. 23 indexed citations
14.
Busca, Alessandro, Roberto Passera, Enrico Maffini, et al.. (2018). Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting. Bone Marrow Transplantation. 53(10). 1304–1310. 9 indexed citations
15.
Lia, Giuseppe, Lucia Brunello, Stefania Bruno, et al.. (2017). Extracellular vesicles as potential biomarkers of acute graft-vs-host disease. Leukemia. 32(3). 765–773. 30 indexed citations
16.
Giaccone, Luisa, Andrea Evangelista, Francesca Patriarca, et al.. (2017). Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft–Allograft in Multiple Myeloma. Biology of Blood and Marrow Transplantation. 24(1). 189–193. 14 indexed citations
17.
Giaccone, Luisa, Moreno Festuccia, Francesco Zallio, et al.. (2017). Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma. Bone Marrow Transplantation. 52(8). 1208–1211. 5 indexed citations
18.
Maffini, Enrico, Luisa Giaccone, Moreno Festuccia, et al.. (2016). Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation. Expert Review of Hematology. 9(6). 585–596. 36 indexed citations
19.
Maffini, Enrico, Moreno Festuccia, Lucia Brunello, et al.. (2016). Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 23(3). 388–397. 50 indexed citations
20.
Giaccone, Luisa, Lucia Brunello, Roberto Passera, et al.. (2013). Immunophenotypic Response After Allografting In Multiple Myeloma. Blood. 122(21). 3371–3371. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moreno Festuccia Breakdown of academic impact, for papers by Amer Beitinjaneh Breakdown of academic impact, for papers by Lena Oevermann Breakdown of academic impact, for papers by Motoko Koyama Breakdown of academic impact, for papers by Brenda J. Kitchen Breakdown of academic impact, for papers by Rik A. Brooimans Breakdown of academic impact, for papers by Shuji Ohta Breakdown of academic impact, for papers by Victoria Bordon Breakdown of academic impact, for papers by Juan Manuel Torres Breakdown of academic impact, for papers by G Prentice
Rankless by CCL
2026